Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Titan Bio-Tech: Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31 2026 And To Recommend Dividend If Any On The Equity Shares Of The Company For The Financial Year 2025-26.
News Announcement

Titan Bio-Tech: Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31 2026 And To Recommend Dividend If Any On The Equity Shares Of The Company For The Financial Year 2025-26.

20-May-2026 Follow Value Research Online on Google download pdfDownload PDF Titan Bio-Tech

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the audited financial results (standalone and consolidated) and to recommend dividend if any.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan